Interpace Biosciences, Inc.
IDXG· OTC
IDXGInterpace Biosciences, Inc.
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001054102-12-000027
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $27.81M | $38.64M | $32.85M |
| Net Income | -$439.00K | -$895.00K | -$890.00K |
| EPS Diluted | -$0.03 | -$0.06 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end
